3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Sarcoma
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Leukemia, Biphenotypic, Acute
2
Ganglioneuroblastoma
2
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Degradation of Top2b and Top2a in Human by Dexrazoxane
1
Cardiotoxicity
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
Magnetic Resonance Spectroscopy
8
X-Rays
7
Phantoms, Imaging
7
Cyclophosphamide
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
fludarabine
4
Etoposide
4
Biopsy
4
tazemetostat
3
etoposide phosphate
3
Vincristine
3
Temozolomide
3
Nivolumab
3
Cisplatin
3
Carboplatin
3
Automobiles
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Topotecan
2
Sirolimus
2
Methotrexate
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Dexrazoxane
×
1 year
×
Clear all
No trials found.